GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Artivion Inc (NYSE:AORT) » Definitions » Cyclically Adjusted Price-to-FCF

Artivion (Artivion) Cyclically Adjusted Price-to-FCF : 209.91 (As of Jun. 10, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Artivion Cyclically Adjusted Price-to-FCF?

As of today (2024-06-10), Artivion's current share price is $23.09. Artivion's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was $0.11. Artivion's Cyclically Adjusted Price-to-FCF for today is 209.91.

The historical rank and industry rank for Artivion's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

AORT' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 25.89   Med: 74.33   Max: 368.33
Current: 214.4

During the past years, Artivion's highest Cyclically Adjusted Price-to-FCF was 368.33. The lowest was 25.89. And the median was 74.33.

AORT's Cyclically Adjusted Price-to-FCF is ranked worse than
94.92% of 236 companies
in the Medical Devices & Instruments industry
Industry Median: 42.675 vs AORT: 214.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Artivion's adjusted free cash flow per share data for the three months ended in Mar. 2024 was $-0.190. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $0.11 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Artivion Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Artivion's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artivion Cyclically Adjusted Price-to-FCF Chart

Artivion Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 77.29 75.59 88.73 88.20 160.28

Artivion Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.70 138.49 138.48 160.28 194.38

Competitive Comparison of Artivion's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Artivion's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artivion's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Artivion's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Artivion's Cyclically Adjusted Price-to-FCF falls into.



Artivion Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Artivion's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=23.09/0.11
=209.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artivion's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Artivion's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.19/131.7762*131.7762
=-0.190

Current CPI (Mar. 2024) = 131.7762.

Artivion Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.058 100.560 0.076
201409 0.055 100.428 0.072
201412 0.131 99.070 0.174
201503 0.009 99.621 0.012
201506 0.100 100.684 0.131
201509 0.134 100.392 0.176
201512 0.039 99.792 0.051
201603 0.019 100.470 0.025
201606 0.074 101.688 0.096
201609 0.209 101.861 0.270
201612 0.070 101.863 0.091
201703 0.055 102.862 0.070
201706 -0.123 103.349 -0.157
201709 0.052 104.136 0.066
201712 0.123 104.011 0.156
201803 -0.328 105.290 -0.411
201806 -0.013 106.317 -0.016
201809 0.197 106.507 0.244
201812 0.246 105.998 0.306
201903 -0.001 107.251 -0.001
201906 -0.037 108.070 -0.045
201909 0.295 108.329 0.359
201912 -0.047 108.420 -0.057
202003 0.003 108.902 0.004
202006 -0.123 108.767 -0.149
202009 0.166 109.815 0.199
202012 0.085 109.897 0.102
202103 -0.117 111.754 -0.138
202106 -0.080 114.631 -0.092
202109 -0.155 115.734 -0.176
202112 -0.054 117.630 -0.060
202203 -0.083 121.301 -0.090
202206 -0.241 125.017 -0.254
202209 0.028 125.227 0.029
202212 -0.058 125.222 -0.061
202303 -0.223 127.348 -0.231
202306 0.140 128.729 0.143
202309 0.141 129.860 0.143
202312 0.218 129.419 0.222
202403 -0.190 131.776 -0.190

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Artivion  (NYSE:AORT) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Artivion Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Artivion's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Artivion (Artivion) Business Description

Traded in Other Exchanges
Address
1655 Roberts Boulevard North West, Kennesaw, GA, USA, 30144
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
Executives
Jean F Holloway officer: VP, General Counsel C/O ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
John E Davis officer: Senior VP, Global Sales 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Amy Horton officer: Chief Accounting Officer C/O CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW GA 30144
Florian Tyrs officer: VP, Global Operations IM SOELLER 3, BALINGEN 2M 72336
Robert C Thomson officer: VP Research & Development 33 HABERSHAM COVE DRIVE, NW, ATLANTA GA 30305
Matthew A Getz officer: VP, Human Resources 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Dennis B Maier officer: Vice President, Operations 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Rochelle L. Maney officer: VP, Quality 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
James P Mackin officer: President & CEO ARTIVION, INC., 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Marshall S. Stanton officer: SVP, Clinical & MD Affair 1655 ROBERTS BLVD, NW, KENNESAW GA 30144
Andrew M Green officer: VP Regulatory ARTIVION INC, 1655 ROBERTS BLVD, KENNESAW GA 30144
David Ashley Lee officer: Executive VP, COO & CFO C/O CRYOLIFE INC, 1655 ROBERTS BLVD NW, KENNESAW GA 30144
Elizabeth A Hoff director 2701 WESTHEIMER ROAD, UNIT 1-E, HOUSTON TX 77098
Anthony B. Semedo director 3288 HARRISON GRADE ROAD, SEBASTOPOL CA 95472
Ronald D Mccall director C/O CRYOLIFE, INC., 1655 ROBERTS BOULEVARD, NW, KENNESAW GA 30144